 |
OMass Therapeutics
Last updated: January 21, 2024
Ros Deegan, CEO
Country: UK | Funding: £128M (+)
Website: https://www.omass.com/
OMass Therapeutics develops new medicines against highly validated but inadequately drugged targets using novel biochemistry techniques, native mass spectrometry and custom chemistry.
Website: https://www.omass.com/
OMass Therapeutics develops new medicines against highly validated but inadequately drugged targets using novel biochemistry techniques, native mass spectrometry and custom chemistry.
